293 related articles for article (PubMed ID: 36426803)
1. Management of Lung Cancer in the Patient with Interstitial Lung Disease.
Frank AJ; Dagogo-Jack I; Dobre IA; Tait S; Schumacher L; Fintelmann FJ; Fingerman LM; Keane FK; Montesi SB
Oncologist; 2023 Jan; 28(1):12-22. PubMed ID: 36426803
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and Treatment of Lung Cancer in the Setting of Interstitial Lung Disease.
Fisher DA; Murphy MC; Montesi SB; Hariri LP; Hallowell RW; Keane FK; Lanuti M; Mooradian MJ; Fintelmann FJ
Radiol Clin North Am; 2022 Nov; 60(6):993-1002. PubMed ID: 36202484
[TBL] [Abstract][Full Text] [Related]
3. Is Thoracic Radiotherapy an Absolute Contraindication for Treatment of Lung Cancer Patients With Interstitial Lung Disease? A Systematic Review.
Saha A; Dickinson P; Shrimali RK; Salem A; Agarwal S
Clin Oncol (R Coll Radiol); 2022 Dec; 34(12):e493-e504. PubMed ID: 35168842
[TBL] [Abstract][Full Text] [Related]
4. [Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease].
Huang C; Ma C; Wu Q; Jiao P; Sun Y; Tian W; Yu H; Huang W; Wang Y; Tong H
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):343-350. PubMed ID: 32429636
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Management of Fibrotic Interstitial Lung Diseases.
Collins BF; Luppi F
Clin Chest Med; 2021 Jun; 42(2):321-335. PubMed ID: 34024407
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of preexisting interstitial lung disease in Japanese patients with small-cell lung cancer.
Togashi Y; Masago K; Handa T; Tanizawa K; Okuda C; Sakamori Y; Nagai H; Kim YH; Mishima M
Clin Lung Cancer; 2012 Jul; 13(4):304-11. PubMed ID: 22169479
[TBL] [Abstract][Full Text] [Related]
7. The Role of Surgical Lung Biopsy in the Diagnosis of Fibrotic Interstitial Lung Disease: Perspective from the Pulmonary Fibrosis Foundation.
Hariri LP; Roden AC; Chung JH; Danoff SK; Gomez Manjarres DC; Hartwig M; Kheir F; King C; Kreider M; Lynch DA; Mooney J; Muniappan A; Myers JL; Paoletti L; Raj R; Safdar Z; Suliman S; Thavarajah K; Lederer DJ; Rudell FL; Bianchi P; Shea BS; Ley B
Ann Am Thorac Soc; 2021 Oct; 18(10):1601-1609. PubMed ID: 34004127
[TBL] [Abstract][Full Text] [Related]
8. Interstitial lung disease in systemic sclerosis.
Bussone G; Mouthon L
Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
[TBL] [Abstract][Full Text] [Related]
9. Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis.
Nakajima M; Yamamoto N; Hayashi K; Karube M; Ebner DK; Takahashi W; Anzai M; Tsushima K; Tada Y; Tatsumi K; Miyamoto T; Tsuji H; Fujisawa T; Kamada T
Radiat Oncol; 2017 Sep; 12(1):144. PubMed ID: 28865463
[TBL] [Abstract][Full Text] [Related]
10. Current pharmacotherapies for advanced lung cancer with pre-existing interstitial lung disease : A literature review and future perspectives.
Hanibuchi M; Ogino H; Sato S; Nishioka Y
J Med Invest; 2024; 71(1.2):9-22. PubMed ID: 38735730
[TBL] [Abstract][Full Text] [Related]
11. Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases.
Fischer A; Distler J
Clin Rheumatol; 2019 Oct; 38(10):2673-2681. PubMed ID: 31423560
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy-related pneumonitis and the synergic impact of thoracic radiation and preexisting interstitial lung disease.
Azhar M; Abrencillo R; Gandhi S; Altan M; Sheshadri A
Curr Opin Pulm Med; 2023 Jul; 29(4):248-255. PubMed ID: 37170920
[TBL] [Abstract][Full Text] [Related]
13. Unclassifiable interstitial lung disease: A review.
Skolnik K; Ryerson CJ
Respirology; 2016 Jan; 21(1):51-6. PubMed ID: 26059704
[TBL] [Abstract][Full Text] [Related]
14. Interstitial lung diseases in the hospitalized patient.
Disayabutr S; Calfee CS; Collard HR; Wolters PJ
BMC Med; 2015 Sep; 13():245. PubMed ID: 26407727
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease.
Dodia N; Amariei D; Kenaa B; Corwin D; Chelala L; Britt EJ; Sachdeva A; Luzina IG; Hasday JD; Shah NG; Atamas SP; Franks TJ; Burke AP; Hines SE; Galvin JR; Todd NW
Respir Med; 2021 Apr; 179():106333. PubMed ID: 33676119
[TBL] [Abstract][Full Text] [Related]
16. The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease: Dilemmas in Diagnosis and the Conundrum of Treatment.
King CS; Shlobin OA
Chest; 2020 Oct; 158(4):1651-1664. PubMed ID: 32387520
[TBL] [Abstract][Full Text] [Related]
17. Organizing Pneumonia after Nivolumab Treatment in a Patient with Pathologically Proven Idiopathic Pulmonary Fibrosis.
Kashiwada T; Minegishi Y; Saito Y; Kato T; Atsumi K; Seike M; Kubota K; Terasaki Y; Gemma A
J Nippon Med Sch; 2019; 86(1):43-47. PubMed ID: 30918156
[TBL] [Abstract][Full Text] [Related]
18. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
19. Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease.
Kawase S; Hattori N; Ishikawa N; Horimasu Y; Fujitaka K; Furonaka O; Isobe T; Miyoshi S; Hamada H; Yamane T; Yokoyama A; Kohno N
Respir Res; 2011 Jul; 12(1):97. PubMed ID: 21791074
[TBL] [Abstract][Full Text] [Related]
20. Advances with pharmacotherapy for the treatment of interstitial lung disease.
Comes A; Sgalla G; Perrotta A; Richeldi L
Expert Opin Pharmacother; 2022 Mar; 23(4):483-495. PubMed ID: 34907821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]